DAVID
BERNARDO ORDIZ
PROFESORA SUSTITUTA/PROFESOR SUSTITUTO
![Foto de DAVID](/img/nophoto.png)
![Foto de Universidad Autónoma de Madrid](/img/noimage_org.png)
Universidad Autónoma de Madrid
Madrid, EspañaUniversidad Autónoma de Madrid-ko ikertzaileekin lankidetzan egindako argitalpenak (10)
2023
-
A second update on mapping the human genetic architecture of COVID-19
Nature
-
Expression of HMGCS2 in intestinal epithelial cells is downregulated in inflammatory bowel disease associated with endoplasmic reticulum stress
Frontiers in immunology, Vol. 14, pp. 1185517
2022
-
A first update on mapping the human genetic architecture of COVID-19
Nature
-
Metabolomics study of COVID-19 patients in four different clinical stages
Scientific reports, Vol. 12, Núm. 1, pp. 1650
-
Novel genes and sex differences in COVID-19 severity
Human molecular genetics, Vol. 31, Núm. 22, pp. 3789-3806
-
Whole-genome sequencing reveals host factors underlying critical COVID-19
Nature, Vol. 607, Núm. 7917, pp. 97-103
2021
-
Lunasin Peptide is a Modulator of the Immune Response in the Human Gastrointestinal Tract
Molecular Nutrition and Food Research, Vol. 65, Núm. 12
-
Profiling of Human Circulating Dendritic Cells and Monocyte Subsets Discriminates between Type and Mucosal Status in Patients with Inflammatory Bowel Disease
Inflammatory Bowel Diseases, Vol. 27, Núm. 2, pp. 268-274
2020
-
Serum adipokines as non-invasive biomarkers in Crohn’s disease
Scientific Reports, Vol. 10, Núm. 1
2018
-
Human intestinal pro-inflammatory CD11chighCCR2+CX3CR1+ macrophages, but not their tolerogenic CD11c-CCR2-CX3CR1- counterparts, are expanded in inflammatory bowel disease article
Mucosal Immunology, Vol. 11, Núm. 4, pp. 1114-1126